FDA OKs Phase 3 Trial of Masitinib & New Year Hopes

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a masitinib trial that is expected to include up to 800 participants at about 75 sites in Europe, North America, Israel, and Africa.

He also reads “This New Year, I Resolve to Let Myself Hope” by Benjamin Hofmeister, from his column “Chairborne.”

===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/